Paclitaxel Prodrug Nanomedicine for Potential CT-imaging Guided Breast Cancer Therapy

Jia-Wei Chen; Yi Shen; Qing-Song Yu; Zhi-Hua Gan

doi:10.1007/s10118-023-2958-7

Your Location：

Home >

Browse articles >

Paclitaxel Prodrug Nanomedicine for Potential CT-imaging Guided Breast Cancer Therapy

RESEARCH ARTICLE | Updated：2023-11-10

- Paclitaxel Prodrug Nanomedicine for Potential CT-imaging Guided Breast Cancer Therapy
  Enhanced Publication
- Chinese Journal of Polymer Science Vol. 41, Issue 11, Pages: 1747-1759(2023)
- Affiliations：
  
  1.State Key Laboratory of Organic-Inorganic Composite Materials, Beijing Laboratory of Biomedical Materials, Beijing Advanced Innovation Center for Soft Matter Science and Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China
- Author bio：
  
  yuqs@mail.buct.edu.cn
- Funds：
- DOI：10.1007/s10118-023-2958-7
  CLC：
Scan for full text
Chen, J. W.; Shen, Y.; Yu, Q. S.; Gan, Z. H. Paclitaxel prodrug nanomedicine for potential CT-imaging guided breast cancer therapy. Chinese J. Polym. Sci. 2023, 41, 1747–1759

Jia-Wei Chen, Yi Shen, Qing-Song Yu, et al. Paclitaxel Prodrug Nanomedicine for Potential CT-imaging Guided Breast Cancer Therapy. [J]. Chinese Journal of Polymer Science 41(11):1747-1759(2023)
Chen, J. W.; Shen, Y.; Yu, Q. S.; Gan, Z. H. Paclitaxel prodrug nanomedicine for potential CT-imaging guided breast cancer therapy. Chinese J. Polym. Sci. 2023, 41, 1747–1759 DOI： 10.1007/s10118-023-2958-7.

Jia-Wei Chen, Yi Shen, Qing-Song Yu, et al. Paclitaxel Prodrug Nanomedicine for Potential CT-imaging Guided Breast Cancer Therapy. [J]. Chinese Journal of Polymer Science 41(11):1747-1759(2023) DOI： 10.1007/s10118-023-2958-7.

摘要

The prodrug strategy significantly increased the encapsulation efficiency and cancer cell selectivity of paclitaxel. The iodination endows the nanoparticles with CT-imaging capacity. The GSH-responsiveness of polymer further facilitates the intracellular drug release. Therefore, efficient antitumor therapy and real-time monitoring of the therapeutic efficacy might be simultaneously achieved.

Abstract

Nanotheranostics, which combine the therapeutic and diagnostic functions in one integrated system, have received extensive attentions in cancer treatments because they enable non-invasive diagnosis, tumor-targeted drug delivery, and real-time monitoring of therapeutic response. However, due to the high systemic toxicity of commonly used chemotherapeutics, current treatment still has limitations. Herein, to simultaneously achieve safe cancer therapy and therapeutic response monitoring, an iodinated prodrug strategy was proposed. 2,3,5-Triiodobenzoic acid (TIBA) was used to modify both paclitaxel (PTX) and the polymeric vehicle, so that the encapsulation efficiency of PTX could be increased and the systemic toxicity could be reduced. As-prepared prodrug nanoparticles could accumulate passively in the tumor site and promptly release loaded drugs in response to the overexpressed GSH in cancer cells, which then caused efficient cell cycle arrest and apoptosis like that of the parent PTX. With this rational design, safe and efficient antitumor therapy and real-time computer tomography (CT) imaging could be simultaneously realized, facilitating potential CT imaging-guided therapy of metastatic breast cancer.

关键词

Keywords

CT imagingPaclitaxelProdrugGSH responsivenessPolymeric nanoparticles

references

Lammers,T.;Aime,S.;Hennink,W.E.;Storm,G.;Kiessling,F.Theranosticnanomedicine.Acc. Chem. Res.2011,44,1029−1038..

Ma,X.;Zhao,Y.;Liang,X.J.Theranosticnanoparticlesengineeredforclinicandpharmaceutics.Acc. Chem. Res.2011,44,1114−1122..

Ryu,J.H.;Koo,H.;Sun,I.C.;Yuk,S.H.;Choi,K.;Kim,K.;Kwon,I.C.Tumor-targetingmulti-functionalnanoparticlesfortheragnosis:newparadigmforcancertherapy.Adv. Drug Deliv. Rev.2012,64,1447−1458..

Lee,D.E.;Koo,H.;Sun,I.C.;Ryu,J.H.;Kim,K.;Kwon,I.C.Multifunctionalnanoparticlesformultimodalimagingandtheragnosis.Chem. Soc. Rev.2012,41,2656−72..

Al-Buriahi,M.S.;Tonguc,B.T.Massattenuationcoefficients,effectiveatomicnumbersandelectrondensitiesofsomecontrastagentsforcomputedtomography.Radiat. Phys. Chem.2020,166,108507..

Wang,M.;Chang,M.;Chen,Q.;Wang,D.;Li,C.;Hou,Z.;Lin,J.;Jin,D.;Xing,B.Au(2)Pt-PEG-Ce6nanoformulationwithdualnanozymeactivitiesforsynergisticchemodynamictherapy/phototherapy.Biomaterials2020,252,120093..

Choi,J.Y.;Lee,J.M.;Sirlin,C.B.CTandMRimagingdiagnosisandstagingofhepatocellularcarcinoma:PartII.Extracellularagents,hepatobiliaryagents,andancillaryimagingfeatures.Radiology2014,273,30−50..

Liu,Y.;Ai,K.;Lu,L.NanoparticulateX-raycomputedtomographycontrastagents:fromdesignvalidationtoin vivoapplications.Acc. Chem. Res.2012,45,1817−1827..

Lee,N.;Choi,S.H.;Hyeon,T.Nano-sizedCTcontrastagents.Adv. Mater.2013,25,2641−2660..

Potier,M.;Lagroye,I.;Lakhdar,B.;Cambar,J.;Idee,J.M.Comparativecytotoxicityoflow-andhigh-osmolarcontrastmediatohumanfibroblastsandratmesangialcellsinculture.Invest. Radiol.1997,32,621−626..

Hallouard,F.;Anton,N.;Choquet,P.;Constantinesco,A.;Vandamme,T.IodinatedbloodpoolcontrastmediaforpreclinicalX-rayimagingapplications—areview.Biomaterials2010,31,6249−6268..

Zhang,W.L.;Li,N.;Huang,J.;Yu,J.H.;Wang,D.X.;Li,Y.P.;Liu,S.Y.Gadolinium-conjugatedFA-PEG-PAMAM-COOHnanoparticlesaspotentialtumor-targetedcirculation-prolongedmacromolecularMRIcontrastagents.J. Appl. Polym. Sci.2010,118,1805−1814..

Yan,J.;Yin,M.;Foster,F.S.;Démoré,C.E.M.Tumorcontrastimagingwithgasvesiclesbycircumventingthereticuloendothelialsystem.Ultrasound Med. Biol2020,46,359−368..

Rajendran,K.;Petersilka,M.;Henning,A.;Shanblatt,E.R.;Schmidt,B.;Flohr,T.G.;Ferrero,A.;Baffour,F.;Diehn,F.E.;Yu,L.;Rajiah,P.;Fletcher,J.G.;Leng,S.;McCollough,C.H.Firstclinicalphoton-countingdetectorCTsystem:technicalevaluation.Radiology2021,303,130−138..

Bhatt,S.P.;Soler,X.;Wang,X.;Murray,S.;Anzueto,A.R.;Beaty,T.H.;Boriek,A.M.;Casaburi,R.;Criner,G.J.;Diaz,A.A.;Dransfield,M.T.;Curran-Everett,D.;Galban,C.J.;Hoffman,E.A.;Hogg,J.C.;Kazerooni,E.A.;Kim,V.;Kinney,G.L.;Lagstein,A.;Lynch,D.A.;Make,B.J.;Martinez,F.J.;Ramsdell,J.W.;Reddy,R.;Ross,B.D.;Rossiter,H.B.;Steiner,R.M.;Strand,M.J.;vanBeek,E.J.;Wan,E.S.;Washko,G.R.;Wells,J.M.;Wendt,C.H.;Wise,R.A.;Silverman,E.K.;Crapo,J.D.;Bowler,R.P.;Han,M.K.;Investigators,C.O.AssociationbetweenfunctionalsmallairwaydiseaseandFEV1declineinchronicobstructivepulmonarydisease.Am. J. Respir. Crit. Care Med.2016,194,178−84..

Smit,J.;Borm,F.J.;Niemeijer,A.N.;Huisman,M.C.;Hoekstra,O.S.;Boellaard,R.;Oprea-Lager,D.E.;Vugts,D.J.;vanDongen,G.;deWit-vanderVeen,B.J.;Thunnissen,E.;Smit,E.F.;deLangen,A.J.PD-L1PET/CTimagingwithradiolabeleddurvalumabinpatientswithadvanced-stagenon-smallcelllungcancer.J. Nucl. Med.2022,63,686−693..

Sartor,O.;deBono,J.;Chi,K.N.;Fizazi,K.;Herrmann,K.;Rahbar,K.;Tagawa,S.T.;Nordquist,L.T.;Vaishampayan,N.;El-Haddad,G.;Park,C.H.;Beer,T.M.;Armour,A.;Perez-Contreras,W.J.;DeSilvio,M.;Kpamegan,E.;Gericke,G.;Messmann,R.A.;Morris,M.J.;Krause,B.J.;Investigators,V.Lutetium-177-PSMA-617formetastaticcastration-resistantprostatecancer.N. Engl. J. Med.2021,385,1091−1103..

Liu,Q.;Qian,Y.;Li,P.;Zhang,S.;Liu,J.;Sun,X.;Fulham,M.;Feng,D.;Huang,G.;Lu,W.;Song,S.131I-labeledcoppersulfide-loadedmicrospherestotreathepatictumorsviahepaticarteryembolization.Theranostics2018,8,785−799..

Zhu,J.;Wang,G.;Alves,C.S.;Tomás,H.;Xiong,Z.;Shen,M.;Rodrigues,J.;Shi,X.Multifunctionaldendrimer-entrappedgoldnanoparticlesconjugatedwithdoxorubicinforpH-responsivedrugdeliveryandtargetedcomputedtomographyimaging.Langmuir2018,34,12428−12435..

Zalcman,G.;Mazieres,J.;Margery,J.;Greillier,L.;Audigier-Valette,C.;Moro-Sibilot,D.;Molinier,O.;Corre,R.;Monnet,I.;Gounant,V.;Rivière,F.;Janicot,H.;Gervais,R.;Locher,C.;Milleron,B.;Tran,Q.;Lebitasy,M.P.;Morin,F.;Creveuil,C.;Parienti,J.J.;Scherpereel,A.BevacizumabfornewlydiagnosedpleuralmesotheliomaintheMesotheliomaAvastinCisplatinPemetrexedStudy(MAPS):arandomised,controlled,open-label,phase3trial.Lancet2016,387,1405−1414..

Danhier,F.;Lecouturier,N.;Vroman,B.;Jerome,C.;Marchand-Brynaert,J.;Feron,O.;Preat,V.Paclitaxel-loadedPEGylatedPLGA-basednanoparticles:in vitroandin vivoevaluation.J. Control. Rel.2009,133,11−17..

Zhao,J.;Du,J.;Wang,J.;An,N.;Zhou,K.;Hu,X.;Dong,Z.;Liu,Y.Folicacidandpoly(ethyleneglycol)decoratedpaclitaxelnanocrystalsexhibitenhancedstabilityandbreastcancer-targetingcapability.ACS Appl. Mater. Interfaces2021,13,14577−14586..

Liu,Y.;Guo,K.;Ding,M.;Zhang,B.;Xiao,N.;Tang,Z.;Wang,Z.;Zhang,C.;Shubhra,Q.T.H.Engineeredmagneticpolymernanoparticlescanamelioratebreastcancertreatmentinducingpyroptosis-starvationalongwithchemotherapy.ACS Appl. Mater. Interfaces2022,14,42541−42557..

Das,T.;Nandy,S.;Pandey,D.K.;Al-Tawaha,A.R.;Swamy,M.K.;Kumar,V.;Nongdam,P.;Dey,A.12-Anupdateonpaclitaxeltreatmentinbreastcancer.Paclitaxel2022,287−308..

Li,L.;Zhan,Q.;Yi,K.;Chen,N.;Li,X.;Yang,S.;Hou,X.;Zhao,J.;Yuan,X.;Kang,C.EngineeringLipusuwithlysophosphatidylcholineforimprovedtumorcellularuptakeandanticancerefficacy.J. Mater. Chem. B2022,10,1833−1842..

Chen,Q.;Xu,S.;Liu,S.;Wang,Y.;Liu,G.Emergingnanomedicinesofpaclitaxelforcancertreatment.J. Control. Rel.2022,342,280−294..

Luo,C.;Sun,J.;Liu,D.;Sun,B.;Miao,L.;Musetti,S.;Li,J.;Han,X.;Du,Y.;Li,L.;Huang,L.;He,Z.Self-assembledredoxdual-responsiveprodrug-nanosystemformedbysinglethioether-bridgedpaclitaxel-fattyacidconjugateforcancerchemotherapy.Nano Lett.2016,16,5401−5408..

Pei,Q.;Hu,X.;Zheng,X.;Liu,S.;Li,Y.;Jing,X.;Xie,Z.Light-activatableredbloodcellmembrane-camouflageddimericprodrugnanoparticlesforsynergisticphotodynamic/chemotherapy.ACS Nano2018,12,1630−1641..

Luo,T.;Loira-Pastoriza,C.;Patil,H.P.;Ucakar,B.;Muccioli,G.G.;Bosquillon,C.;Vanbever,R.PEGylationofpaclitaxellargelyimprovesitssafetyandanti-tumorefficacyfollowingpulmonarydeliveryinamousemodeloflungcarcinoma.J. Control. Rel.2016,239,62−71..

Yang,D.;Liu,X.;Jiang,X.;Liu,Y.;Ying,W.;Wang,H.;Bai,H.;Taylor,W.D.;Wang,Y.;Clamme,J.P.;Co,E.;Chivukula,P.;Tsang,K.Y.;Jin,Y.;Yu,L.EffectofmolecularweightofPGG–paclitaxelconjugatesonin vitroandin vivoefficacy.J. Control. Rel.2012,161,124−131..

Jiang,M.;Zhang,R.;Wang,Y.;Jing,W.;Liu,Y.;Ma,Y.;Sun,B.;Wang,M.;Chen,P.;Liu,H.;He,Z.Reduction-sensitivepaclitaxelprodrugself-assemblednanoparticleswithtetrandrineeffectivelypromotesynergistictherapyagainstdrug-sensitiveandmultidrug-resistantbreastcancer.Mol. Pharmaceutics2017,14,3628−3635..

Zhai,Y.;Zhou,X.;Jia,L.;Ma,C.;Song,R.;Deng,Y.;Hu,X.;Sun,W.Acetal-linkedpaclitaxelpolymericprodrugbasedonfunctionalizedmPEG-PCLdiblockpolymerforpH-triggereddrugdelivery.Polymers2017,9,698..

Zhang,X.;He,F.;Xiang,K.;Zhang,J.;Xu,M.;Long,P.;Su,H.;Gan,Z.;Yu,Q.CD44-targetedfacileenzymaticactivatablechitosannanoparticlesforefficientantitumortherapyandreversalofmultidrugresistance.Biomacromolecules2018,19,883−895..

Yi,X.;Hu,J.J.;Dai,J.;Lou,X.;Zhao,Z.;Xia,F.;Tang,B.Z.Self-guidingpolymericprodrugmicelleswithtwoaggregation-inducedemissionphotosensitizersforenhancedchemo-photodynamictherapy.ACS Nano2021,15,3026−3037..

Li,Y.;Jiang,Y.;Zheng,Z.;Du,N.;Guan,S.;Guo,W.;Tang,X.;Cui,J.;Zhang,L.;Liu,K.;Yu,Q.;Gan,Z.Co-deliveryofpreciselyprescribedmulti-prodrugcombinationbyanengineerednanocarrierenablesefficientindividualizedcancerchemotherapy.Adv. Mater.2022,34,e2110490..

Wang,Z.;Yang,C.;Zhang,H.;Gao,Y.;Xiao,M.;Wang,Z.;Yang,L.;Zhang,J.;Ren,C.;Liu,J.In situtransformablesupramolecularnanomedicinetargetedactivatinghippopathwayfortriple-negativebreastcancergrowthandmetastasisinhibition.ACS Nano2022,16,14644−14657..

Zhang,C.;Meng,X.;Gong,C.;Zhao,J.;Zhang,K.;Yang,Z.Glutathione-responsivebiodegradablenanoplatformwithendogenousesterase-triggerednitricoxidereleaseforgastherapyandenhancedchemotherapy.ACS Appl. Bio Mater.2021,4,5212−5221..

Yu,K.;Hai,X.;Yue,S.;Song,W.;Bi,S.Glutathione-activatedDNA-Aunanomachineastargeteddrugdeliveryplatformforimaging-guidedcombinationalcancertherapy.Chem. Eng. J.2021,419,129535..

Tan,P.;Cai,H.;Wei,Q.;Tang,X.;Zhang,Q.;Kopytynski,M.;Yang,J.;Yi,Y.;Zhang,H.;Gong,Q.;Gu,Z.;Chen,R.;Luo,K.Enhancedchemo-photodynamictherapyofanenzyme-responsiveprodruginbladdercancerpatient-derivedxenograftmodels.Biomaterials2021,277,121061..

Corrigan,N.;Jung,K.;Moad,G.;Hawker,C.J.;Matyjaszewski,K.;Boyer,C.Reversible-deactivationradicalpolymerization(controlled/livingradicalpolymerization):fromdiscoverytomaterialsdesignandapplications.Prog. Polym. Sci.2020,111,101311..

Quan,H.;Fan,L.;Huang,Y.;Xia,X.;He,Y.;Liu,S.;Yu,J.Hyaluronicacid-decoratedcarborane-TATconjugationnanomicelles:apotentialboronagentwithenhancedselectivityoftumorcellularuptake.Colloids Surf. B2021,204,111826..

Cheng,R.;Feng,F.;Meng,F.;Deng,C.;Feijen,J.;Zhong,Z.Glutathione-responsivenano-vehiclesasapromisingplatformfortargetedintracellulardrugandgenedelivery.J. Control. Rel.2011,152,2−12..

Cuggino,J.C.;Gatti,G.;Picchio,M.L.;Maccioni,M.;Gugliotta,L.M.;AlvarezIgarzabal,C.I.Duallyresponsivenanogelsassmartcarriersforimprovingthetherapeuticindexofdoxorubicinforbreastcancer.Eur. Polym. J.2019,116,445−452..

Jin,Q.;Deng,Y.;Chen,X.;Ji,J.Rationaldesignofcancernanomedicineforsimultaneousstealthsurfaceandenhancedcellularuptake.ACS Nano2019,13,954−977..

Khorsand,B.;Lapointe,G.;Brett,C.;Oh,J.K.Intracellulardrugdeliverynanocarriersofglutathione-responsivedegradableblockcopolymershavingpendantdisulfidelinkages.Biomacromolecules2013,14,2103−2111..

Borkowska,M.;Siek,M.;Kolygina,D.V.;Sobolev,Y.I.;Lach,S.;Kumar,S.;Cho,Y.K.;Kandere-Grzybowska,K.;Grzybowski,B.A.Targetedcrystallizationofmixed-chargenanoparticlesinlysosomesinducesselectivedeathofcancercells.Nat. Nanotechnol.2020,15,331−341..

Qian,J.;Xu,Z.;Meng,C.;Liu,Y.;Wu,H.;Wang,Y.;Yang,J.;Zheng,H.;Ran,F.;Liu,G.Q.;Ling,Y.Redox-activatabletheranosticco-prodrugforprecisetumordiagnosisandselectivecombinationchemotherapy.J. Med. Chem.2022,65,10393−10407..

Angelucci,A.;Mari,M.;Millimaggi,D.;Giusti,I.;Carta,G.;Bologna,M.;Dolo,V.Suberoylanilidehydroxamicacidpartlyreversesresistancetopaclitaxelinhumanovariancancercelllines.Gynecol. Oncol.2010,119,557−563..

Cheng,G.;Zong,W.;Guo,H.;Li,F.;Zhang,X.;Yu,P.;Ren,F.;Zhang,X.;Shi,X.;Gao,F.;Chang,J.;Wang,S.Programmedsize-changeablenanotheranosticagentsforenhancedimaging-guidedchemo/photodynamiccombinationtherapyandfastelimination.Adv. Mater.2021,33,2100398..

Kelkar,S.S.;Hill,T.K.;Marini,F.C.;Mohs,A.M.Nearinfraredfluorescentnanoparticlesbasedonhyaluronicacid:self-assembly,opticalproperties,andcellinteraction.Acta Biomater.2016,36,112−121..

Ginn-Hedman,A.M.;Self,T.S.;Jessen,S.L.;Heaps,C.L.;Weeks,B.R.;Clubb,F.J.Jr.Diffusiblecontrast-enhancedmicro-CTimprovesvisualizationofstentedvessels.Cardiovasc. Pathol.2022,60,107428..

Louage,B.;VanSteenbergen,M.J.;Nuhn,L.;Risseeuw,M.D.P.;Karalic,I.;Winne,J.;VanCalenbergh,S.;Hennink,W.E.;DeGeest,B.G.Micellarpaclitaxel-initiatedRAFTpolymerconjugateswithacid-sensitivebehavior.ACS Macro Lett.2017,6,272−276..

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Responsive Polymeric Nanoparticles for Biofilm-infection Control

ABA TRIBLOCK COPOLYMERS WITH PENDANT HYDROXYL GROUPS PREPARED BY CONTROLLED CATIONIC POLYMERIZATION AND THEIR USE AS DELIVERY CARRIER FOR PACLITAXEL

Related Author

No data

Related Institution

State Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Functional Polymer Materials, Ministry of Education, Institute of Polymer Chemistry, College of Chemistry, Nankai University

Engineering Research Center of Clinical Functional Materials and Diagnosis & Treatment Devices of Zhejiang Province, Wenzhou Institute, University of Chinese Academy of Sciences; Oujiang Laboratory

College of Material Science and Engineering, Beijing University of Chemical Technology

Department of Material Science and Engineering, Beijing Institute of Petrochemical Technology

⁰